Mandate

Vinge has advised Bragnum Invest with their acquisition of SkySparc

July 08, 2019 M&A

Vinge has advised Bragnum Invest with their acquisition of SkySparc, an independent solutions provider trusted by banks, central banks, Fortune 100 corporate treasuries and asset managers and offers complementary software, outsourced support and a wide range of financial and technical consulting services.

The core team consisted of Christina Kokko, project leaders Hedvig Ekdahl and Christina Odengran, Ulrich Ziche, Lisa Ullman, Sarah Berger, Agnes Perbo, Christopher Widström, Ilze Lukins and Victoria Owetz.

Existing SkySparc owners and staff will remain significant shareholders in the company.
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025